Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Total Current Liabilities (2017 - 2026)

Equillium (EQ) posted quarterly Total Current Liabilities of $3.3 million for Q1 2026, down 44.27% year-over-year from $6.0 million in Q1 2025, and up 14.01% quarter-over-quarter from $2.9 million in Q4 2025.

Analysis

Equillium (EQ) Total Current Liabilities (2017 - 2026) Analysis & Trends

Equillium (EQ) has reported Total Current Liabilities for 10 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 44.27% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 44.27% YoY), while the FY2025 annual figure was $2.9 million, down 53.84% from the prior year.
  • Total Current Liabilities grew to $3.3 million in Q1 2026 per EQ's latest filing, from $2.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $32.0 million in Q4 2022 and bottomed at $2.9 million in Q4 2025.
  • Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $14.9 million in 2022.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities soared 259.37% — and 2024, when it slumped 76.95%.
  • Equillium's Total Current Liabilities stood at $32.0 million in 2022, then declined by 13.94% to $27.6 million in 2023, then plunged by 76.95% to $6.4 million in 2024, then plunged by 53.84% to $2.9 million in 2025, then increased by 14.01% to $3.3 million in 2026.
  • Business Quant data shows EQ's Total Current Liabilities at $3.3 million in Q1 2026, $2.9 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Equillium 249.33 Mn 249.33 Mn - 2.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.48 Mn
Mar 31, 2026 3.35 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 7.23 Mn
Mar 31, 2025 6.00 Mn
Dec 31, 2024 6.36 Mn
Sep 30, 2024 11.06 Mn
Jun 30, 2024 20.17 Mn
Mar 31, 2024 22.21 Mn
Dec 31, 2023 27.57 Mn
Sep 30, 2023 28.20 Mn
Jun 30, 2023 25.22 Mn
Mar 31, 2023 32.02 Mn
Dec 31, 2022 32.04 Mn
Sep 30, 2022 14.93 Mn
Jun 30, 2022 15.19 Mn
Mar 31, 2022 13.11 Mn
Dec 31, 2021 8.92 Mn
Sep 30, 2021 7.78 Mn